Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

High Bleeding Risk & DES Use in ACS Patients

Am J Cardiol; ePub 2017 Jul 24; Alraies, et al

The presence of high bleeding risk (HBR) has a significant impact upon the decision to use drug-eluting stents (DES) in patients presenting with acute coronary syndrome (ACS), a recent study found. The study evaluated the likelihood of receiving DES during percutaneous coronary intervention (PCI) in HBR populations and identified consecutive patients who underwent PCI from April 2003 to September 2015. HBR was defined as patients fulfilling ≥1 of the HBR criteria: age ≥75 years, anticoagulation use at discharge, history of stroke, cancer in previous 3 years, glucocorticoid use, hemoglobin <11 g/dL, platelet count <100,000/mm3, or creatinine clearance (CCr) <40 ml/min. Researchers found:

  • 10,5954 patients met HBR definition.
  • Patients with HBR were less likely to receive a DES compared with non-HRB patients (OR, 0.58).
  • A preprocedure hemoglobin <11 g/dL had the greatest association with choosing DES during PCI (OR, 0.51).
  • Patients having ≥3 HBR criteria had lower likelihood of receiving a DES.

Citation:

Alraies MC, Lee SY, Lipinski MJ, et al. Effect of bleeding risk on type of stent used in patients presenting with acute coronary syndromes. [Published online ahead of print July 24, 2017]. Am J Cardiol. doi:10.1016/j.amjcard.2017.07.013.

This Week's Must Reads

Anticoagulation in Patients with AF and HF, Clin Cardiol; ePub 2018 Dec 23; Contreras, et al

Serum Uric Acid, Silent MI & Mortality, Am J Cardiol; ePub 2018 Dec 19; Ahmad, et al

Catheter Ablation for AF in Adults with CHD, Heart Rhythm; ePub 2018 Dec 26; Liang, et al

Cognitive Impairment in Adults with Incident HF, J Card Fail; ePub 2018 Dec 22; Sterling, et al

LDL-C Level Reduction Consistent with Evolocumab , JAMA Cardiol; ePub 2018 Dec 12; Qamar, et al

Must Reads in Acute Coronary Syndromes

Serum Uric Acid, Silent MI & Mortality, Am J Cardiol; ePub 2018 Dec 19; Ahmad, et al

Treatment Gap in Primary Prevention Patients with ACS, Am J Cardiol; ePub 2018 Nov 7; Bavishi, et al

BP Goals & CV Outcomes in Patients with T2D, J Am Heart Assoc; ePub 2018 Oct 14; White, et al

PCI Trends Among Elderly Patients with ACS, Am J Cardiol; ePub 2018 Sep 27; Elbadawi, et al

Barriers to Healthcare Access After an ACS, Am J Cardiol; ePub 2018 Jul 15; Erskine, et al